Learning Objectives

After watching this webinar, participants will be able to:

• understand the clinical efficacy of T-TEER in the treatment of severe isolated secondary tricuspid regurgitation;
• evaluate the safety profile and procedural outcomes associated with T-TEER for severe isolated secondary tricuspid regurgitation; and
• assess the impact of TEER on patient quality of life and symptom relief in cases of severe isolated secondary tricuspid regurgitation.

Needs assessment and expected educational outcome

To improve treatment strategies by understanding the efficacy and safety of using T-TEER to treat severe STR and to promote long-term symptom relief with improved QoL. 

Read the article :

Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation : The Tri.Fr Randomized Clinical Trial

Main Topic

• Interventional Cardiology - Noncoronary Cardiac Intervention – Tricuspid Valve Intervention 

Session information

This webinar is designed for early career interventional cardiologists, interventional cardiology fellows, residents interested in interventional cardiology, ESC & EAPCI members wishing to update their scientific knowledge on the topic. 

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).